1-1 of 1
Dan Xiao
Close
Sort by
Journal Articles

Retrospective Analysis of Clinical Outcomes of Utilizing R-CHOP Plus Zanubrutinib for High-Risk Diffuse Large B Cell Lymphoma Patients with Extranodal Involvement or MYC/BCL2 Double Expression

Wanbin Fu, Jia Liu, Dan Xiao, Huanbin Zhao, Ting Wang, Jiong Hu, Jian Hou, Hua Zhong, Lan Xu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6323.
https://doi.org/10.1182/blood-2023-182704
Published: 2023